Atea Pharmaceuticals shares owned by Citigroup
Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Atea Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Atea Pharmaceuticals held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Atea Pharmaceuticals by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $29k | 5.4k | 5.38 |
| 2025-03-31 | $164k | 55k | 3.00 |
| 2024-12-31 | $204k | 61k | 3.35 |
| 2024-09-30 | $194k | 58k | 3.35 |
| 2024-06-30 | $64k | 19k | 3.32 |
| 2024-03-31 | $60k | 15k | 4.04 |
| 2023-12-31 | $38k | 13k | 3.05 |
| 2023-09-30 | $3.2k | 1.1k | 3.00 |
| 2023-03-31 | $9.5k | 2.8k | 3.35 |
| 2022-12-31 | $39k | 8.2k | 4.81 |
| 2022-09-30 | $110k | 19k | 5.67 |
| 2021-12-31 | $366k | 41k | 8.93 |
| 2021-03-31 | $309k | 5.0k | 61.84 |
| 2020-12-31 | $115k | 2.7k | 41.86 |